Novel strategies for treatment of hantavirus-associated human diseases
Projektnummer
0069409
Zusammenfassung
Hantaviruses (order Bunyavirales, family Hantaviridae) are globally emerging pathogens. After transmission to humans via aerosols, hemorrhagic fever with renal syndrome (HFRS) or hantavirus pulmonary syndrome (HPS) involving immunopathogenic processes are observed. As no approved vaccines or therapeutic countermeasures are available, treatment of hantavirus-induced disease in humans is only supportive. In the face of the high pathogenic potential of hantaviruses, the development of appropriate therapeutic strategies and exploration of their underlying mechanism is mandatory. By using a...
Projektinformationen
Status:
Beendet
Startdatum:
01.10.2021
Enddatum:
30.11.2024
Fördersumme:
543.600 €
Profilbereich:
Exploration
Förderinitiative:
Innovative Ansätze in der antiviralen Wirkstoffentwicklung